Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Du

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Molecular Neuroscience : MN|April 27, 2012
Small molecule anticonvulsant agents with potent in vitro neuroprotectionDouglas E Brenneman, Garry R Smith, Yan Zhang, et al.
Bioorganic & Medicinal Chemistry|September 6, 2005
The synthesis and evaluation of 10- and 12-membered ring benzofused enediyne amino acidsYanming Du, Christopher J Creighton, Zhengyin Yan, et al.
Cancers|November 11, 2022
The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy ResistanceMary Abdelmalak, Rajanbir Singh, Mohammed Anwer, et al.
ACS Infectious Diseases|December 12, 2018
Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly InhibitorsXuexiang Zhang, Junjun Cheng, Julia Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infectionsYanming Du, Hong Ye, Tina Gill, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B proteinFuxuan Wang, Zhao Gao, Bo Chen, et al.
Antiviral Research|March 21, 2025
Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivoIchiro Misumi, Zhizhou Yue, Zhengyuan Jiang, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|January 18, 2021
Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virusNicky Hwang, Haiqun Ban, Junjun Chen, et al.
Antiviral Research|July 4, 2024
Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound libraryBiplav Shrestha, Sisi Yang, Lauren Griffith, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2024
"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitroYou Li, Nicky Hwang, Andrew Snedeker, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Molecular Neuroscience : MN|April 27, 2012
Small molecule anticonvulsant agents with potent in vitro neuroprotectionDouglas E Brenneman, Garry R Smith, Yan Zhang, et al.
Bioorganic & Medicinal Chemistry|September 6, 2005
The synthesis and evaluation of 10- and 12-membered ring benzofused enediyne amino acidsYanming Du, Christopher J Creighton, Zhengyin Yan, et al.
Cancers|November 11, 2022
The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy ResistanceMary Abdelmalak, Rajanbir Singh, Mohammed Anwer, et al.
ACS Infectious Diseases|December 12, 2018
Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly InhibitorsXuexiang Zhang, Junjun Cheng, Julia Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infectionsYanming Du, Hong Ye, Tina Gill, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B proteinFuxuan Wang, Zhao Gao, Bo Chen, et al.
Antiviral Research|March 21, 2025
Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivoIchiro Misumi, Zhizhou Yue, Zhengyuan Jiang, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|January 18, 2021
Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virusNicky Hwang, Haiqun Ban, Junjun Chen, et al.
Antiviral Research|July 4, 2024
Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound libraryBiplav Shrestha, Sisi Yang, Lauren Griffith, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2024
"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitroYou Li, Nicky Hwang, Andrew Snedeker, et al.
Pageof 5